| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.38B | — | +11.4% |
| Cost of Revenue | $1.26B | — | +22.1% |
| Gross Profit | $119.0M | — | -42.2% |
| R&D Expense | $458.0M | — | +20.2% |
| SG&A Expense | $542.0M | — | +12.9% |
| Operating Income | -$881.0M | — | -34.5% |
| Pre-tax Income | -$418.0M | — | +22.4% |
| Income Tax | -$2.0M | — | -200.0% |
| Net Income | -$416.0M | — | +23.7% |
| EPS (Basic) | -$0.33 | — | +31.2% |
| EPS (Diluted) | -$0.33 | — | +31.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.85B | -20.5% | -39.4% |
| Short-term Investments | $1.99B | -20.7% | -20.1% |
| Accounts Receivable | $342.0M | -38.4% | -17.0% |
| Inventory | $1.54B | -3.2% | -40.4% |
| Current Assets | $7.04B | -18.0% | -32.2% |
| Total Assets | $14.23B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$703.0M | — | -273.9% |
| Capital Expenditures | $372.0M | — | +10.1% |
| Investing Cash Flow | -$25.0M | — | +93.9% |
| Financing Cash Flow | -$2.0M | — | +66.7% |
| Free Cash Flow | -$1.07B | — | -104.4% |
| -8.2% |
| Current Liabilities | $3.35B | -9.2% | +20.3% |
| Long-term Debt | $4.44B | +0.0% | -0.0% |
| Total Liabilities | $9.80B | -4.5% | +5.7% |
| Stockholders' Equity | $4.43B | -3.6% | -28.9% |